Moneycontrol PRO
Loans
Loans
HomeNewsColgatepalmoliveindia

At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

Jump to
  • Headwinds ahead? Unpacking FMCG firms’ Q2 results

    Headwinds ahead? Unpacking FMCG firms’ Q2 results

    The September quarter results of HUL, ITC, Nestle India and Colgate have thrown up some near-term headwinds, including increased competition and lower-than-expected consumption growth in some pockets, for the FMCG sector

  • Colgate-Palmolive Q2 PAT seen up 17.9% YoY to Rs 327.8 cr: Nirmal Bang

    Colgate-Palmolive Q2 PAT seen up 17.9% YoY to Rs 327.8 cr: Nirmal Bang

    Net Sales are expected to increase by 9.5 percent Y-o-Y (up 14.8 percent Q-o-Q) to Rs 1,519.8 crore, according to Nirmal Bang.

  • Colgate Palmolive Q1 PAT seen up 24.7% YoY to Rs 270.5 cr: Nirmal Bang

    Colgate Palmolive Q1 PAT seen up 24.7% YoY to Rs 270.5 cr: Nirmal Bang

    Net Sales are expected to increase by 7.1 percent Y-o-Y (down 5.1 percent Q-o-Q) to Rs 1,281.4 crore, according to Nirmal Bang.

  • Colgate Palmolive Q4 PAT may dip 14.4% YoY to Rs. 276.8 cr: Nirmal Bang

    Colgate Palmolive Q4 PAT may dip 14.4% YoY to Rs. 276.8 cr: Nirmal Bang

    Net Sales are expected to increase by 6.4 percent Y-o-Y (up 7.2 percent Q-o-Q) to Rs. 1,384.9 crore, according to Nirmal Bang.

  • Colgate Palmolive Q4 PAT may dip 14.4% YoY to Rs. 276.8 cr: Nirmal Bang

    Colgate Palmolive Q4 PAT may dip 14.4% YoY to Rs. 276.8 cr: Nirmal Bang

    Net Sales are expected to increase by 6.4 percent Y-o-Y (up 7.2 percent Q-o-Q) to Rs. 1,384.9 crore, according to Nirmal Bang.

  • Colgate-Palmolive Q3 PAT may dip 0.6% YoY to Rs 250.9 cr: Nirmal Bang

    Colgate-Palmolive Q3 PAT may dip 0.6% YoY to Rs 250.9 cr: Nirmal Bang

    Net Sales are expected to increase by 3.1 percent Y-o-Y (down 4.9 percent Q-o-Q) to Rs 1,319.6 crore, according to Nirmal Bang.

  • Colgate Q2 PAT seen up 4.2% YoY to Rs. 280.4 cr: Motilal Oswal

    Colgate Q2 PAT seen up 4.2% YoY to Rs. 280.4 cr: Motilal Oswal

    Net Sales are expected to increase by 6 percent Y-o-Y (up 19.8 percent Q-o-Q) to Rs. 1,433.6 crore, according to Motilal Oswal.

  • Colgate Palmolive Q1 PAT seen up 5.7% YoY to Rs 246.6 cr: ICICI Direct

    Colgate Palmolive Q1 PAT seen up 5.7% YoY to Rs 246.6 cr: ICICI Direct

    Net Sales are expected to increase by 6.1 percent Y-o-Y (down 4.9 percent Q-o-Q) to Rs 1,236.9 crore, according to ICICI Direct.

  • Colgate Palmolive Q4 PAT may dip 13.5% YoY to Rs. 272.3 cr: ICICI Direct

    Colgate Palmolive Q4 PAT may dip 13.5% YoY to Rs. 272.3 cr: ICICI Direct

    Net Sales are expected to increase by 5.3 percent Y-o-Y (up 5.6 percent Q-o-Q) to Rs. 1,351.7 crore, according to ICICI Direct.

  • Colgate Q4 PAT may dip 14.4% YoY to Rs 269.2 cr: Motilal Oswal

    Colgate Q4 PAT may dip 14.4% YoY to Rs 269.2 cr: Motilal Oswal

    Net Sales are expected to increase by 5.9 percent Y-o-Y (up 6.2 percent Q-o-Q) to Rs 1,359.4 crore, according to Motilal Oswal.

  • Colgate Palmolive Q3 PAT seen up 8.7% YoY to Rs 269.2 cr: KRChoksey

    Colgate Palmolive Q3 PAT seen up 8.7% YoY to Rs 269.2 cr: KRChoksey

    Net Sales are expected to increase by 7.5 percent Y-o-Y (down 2.1 percent Q-o-Q) to Rs 1,352.4 crore, according to KRChoksey.

  • Colgate-Palmolive’s Q2 disappoints; its investors have little to cheer

    Colgate-Palmolive’s Q2 disappoints; its investors have little to cheer

    Colgate-Palmolive's Q2FY22 results are below some analysts’ expectations with operating revenue growth at 5 percent YoY. Note that the company saw double-digit revenue growth in the previous two quarters. Muted sales outlook ahead is one of the chief concerns for the stock.

  • Colgate Palmolive Q2 PAT seen up 8.5% YoY to Rs 297.6 cr: ICICI Direct

    Colgate Palmolive Q2 PAT seen up 8.5% YoY to Rs 297.6 cr: ICICI Direct

    Net Sales are expected to increase by 7.3 percent Y-o-Y (up 18.3 percent Q-o-Q) to Rs 1,379.4 crore, according to ICICI Direct.

  • Colgate Palmolive Q2 PAT seen up 5.5% YoY to Rs 289.3 cr: KRChoksey

    Colgate Palmolive Q2 PAT seen up 5.5% YoY to Rs 289.3 cr: KRChoksey

    Net Sales are expected to increase by 6 percent Y-o-Y (up 16.8 percent Q-o-Q) to Rs 1,362.3 crore, according to KRChoksey.

  • Colgate Q2 PAT may dip 2% YoY to Rs 268.6 cr: Motilal Oswal

    Colgate Q2 PAT may dip 2% YoY to Rs 268.6 cr: Motilal Oswal

    Net Sales are expected to increase by 6 percent Y-o-Y (up 16.9 percent Q-o-Q) to Rs 1,362.6 crore, according to Motilal Oswal.

  • Colgate Palmolive Q1 PAT seen up 22.2% YoY to Rs 242.1 cr: ICICI Direct

    Colgate Palmolive Q1 PAT seen up 22.2% YoY to Rs 242.1 cr: ICICI Direct

    Net Sales are expected to increase by 15.2 percent Y-o-Y (down 6.8 percent Q-o-Q) to Rs 1,198.3 crore, according to ICICI Direct.

  • Colgate Palmolive Q4 PAT seen up 17.1% YoY to Rs. 239.1 cr: ICICI Direct

    Colgate Palmolive Q4 PAT seen up 17.1% YoY to Rs. 239.1 cr: ICICI Direct

    Net Sales are expected to increase by 14.8 percent Y-o-Y (down 4.3 percent Q-o-Q) to Rs. 1,230.3 crore, according to ICICI Direct.

  • Colgate-Palmolive Q4 PAT seen up 12.9% YoY to Rs 223.1 cr: Sharekhan

    Colgate-Palmolive Q4 PAT seen up 12.9% YoY to Rs 223.1 cr: Sharekhan

    Net Sales are expected to increase by 15.5 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs 1,227.3 crore, according to Sharekhan.

  • Colgate Palmolive Q4 PAT seen up 20.3% YoY to Rs. 245.6 cr: KRChoksey

    Colgate Palmolive Q4 PAT seen up 20.3% YoY to Rs. 245.6 cr: KRChoksey

    Net Sales are expected to increase by 7.2 percent Y-o-Y (down 6.8 percent Q-o-Q) to Rs. 1,148.1 crore, according to KRChoksey.

  • Colgate Palmolive: Investment in brands and new products continues

    Colgate Palmolive: Investment in brands and new products continues

    Colgate’s strong brand recall among consumers, new products and higher brand investment should help it garner more market share, going forward

  • Colgate Palmolive Q3 PAT seen up 26% YoY to Rs. 199.1 cr: KR Choksey

    Colgate Palmolive Q3 PAT seen up 26% YoY to Rs. 199.1 cr: KR Choksey

    Net Sales are expected to increase by 2.6 percent Y-o-Y (down 8.5 percent Q-o-Q) to Rs. 1,147.2 crore, according to KR Choksey

  • Colgate Palmolive: Raw material tailwind adds to shine

    Colgate Palmolive: Raw material tailwind adds to shine

    Colgate’s strong brand recall among consumers, new launches and higher brand investment should help it post better market share going forward

  • Colgate Q1 PAT seen up 20.2% YoY to Rs. 200 cr: HDFC Securities

    Colgate Q1 PAT seen up 20.2% YoY to Rs. 200 cr: HDFC Securities

    Net Sales are expected to decrease by 2.9 percent Y-o-Y (down 1.7 percent Q-o-Q) to Rs. 1,050 crore, according to HDFC Securities.

  • Colgate Palmolive earnings call highlights: Real impact of COVID-19 will be seen in Q2, Q3 of this calendar year

    Colgate Palmolive earnings call highlights: Real impact of COVID-19 will be seen in Q2, Q3 of this calendar year

    The company’s focus would be on improving gross margin, while EBITDA margin may be impacted due to change in Ad expenses.

  • Colgate Palmolive (India): Market share stabilises, but it’s already priced in

    Colgate Palmolive (India): Market share stabilises, but it’s already priced in

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347